Search Within

Survivorship Research

Formats
  1. Journal Article (9009)
  2. Meeting Abstract (5248)
  3. Book Section (579)
  4. Review (367)
  5. Editorial (234)
  6. Research Letter (138)
  7. Conference Paper (104)
  8. Correspondence (92)
  9. Guidelines (90)
  10. Miscellaneous (78)
  11. Book Whole (30)
Groups
  1. Department of Medicine (9327)
  2. Population Sciences Research Program (5757)
  3. Solid Tumor Oncology Division (5246)
  4. Surgery (5204)
  5. Epidemiology and Biostatistics (3669)
  6. Division of Subspecialty Medicine (3268)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (792)
  3. Michael Zelefsky (755)
  4. Sergio Giralt (702)
  5. Mark Robson (682)
  6. Joachim Yahalom (634)

More People

Years
  1. 2025 (389)
  2. 2024 (844)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (933)

More Years

Publications
  1. Journal of Clinical Oncology (1892)
  2. International Journal of Radiation Oncology, Biology, Physics (912)
  3. Blood (723)
  4. Annals of Surgical Oncology (604)
  5. Cancer (334)
  6. Cancer Research (333)

More Publications

Publishers
  1. Elsevier Inc. (2394)
  2. American Society of Clinical Oncology (2041)
  3. Springer (1560)
  4. Wiley Blackwell (818)
  5. Oxford University Press (792)
  6. American Society of Hematology (790)

More Publishers

Results (15969)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating leptin and immune-related transcriptomic patterns in clear cell renal cell carcinoma
    Meeting Abstract

    Posada Calderon, L.; Olsson, L.; Kuo, F.; Dawidek, M.; Barbakoff, D.; Ganz, M.; Jiang, H.; Coleman, J. A.; Russo, P.; Furberg, H.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Reliability of photography-based skin tone annotation using the monk scale and 3D total body photography
    Meeting Abstract

    Weir, V. R.; Gillis, M.; Halpern, A. C.; Rotemberg, V.
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Prediction of melanoma metastasis using dermatoscopy deep features: An international multicenter cohort study
    Meeting Abstract

    Lallas, K.; Spyridonos, P.; Kittler, H.; Tschandl, P.; Argenziano, G.; Bakos, R.; Braun, R. P.; Cabo, H.; Dika, E.; Malvehy, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy, safety, and determination of RP2D of ABBV-383, a BCMA bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Valdes, C. R.; Voorhees, P. M.; D'Souza, A.; Chung, A.; Tuchman, S.; Safah, H.; McKay, J. T.; Weisel, K. C.; Teipel, R.; Korde, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Final results of a phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC (MOUNTAINEER)
    Meeting Abstract

    Strickler, J. H.; Cercek, A.; Siena, S.; Andre, T.; Ng, K.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J. M.; Coveler, A. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlative biomarker analyses for optimal therapeutic dose determination of ABBV-383, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ahsan, A.; Mantis, C.; Luo, X.; Zhang, C. C.; Valdes, C. R.; Voorhees, P. M.; D'Souza, A.; Chung, A.; Tuchman, S.; Safah, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlation of TILs indices generated by visual review and digital computational algorithm with outcomes from preoperative chemotherapy for TNBC in TBCRC 030
    Meeting Abstract

    Marta, G. N.; Chu, X.; Mukhopadhyay, S.; Abramson, V. G.; Brufsky, A.; Stringer-Reasor, E. M.; Dent, S. F.; Traina, T. A.; Carey, L. A.; Rimawi, M. F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • ENLIGHTED phase 3 study: Efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) for treatment of low-grade upper tract urothelial cancer (LG UTUC)
    Meeting Abstract

    Margulis, V.; Kaufman, R. P.; Marcq, G.; Shore, N. D.; Colombel, M.; Uchio, E. M.; Psutka, S. P.; Aller, M.; Rausch, S.; Raventos, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • TBCRC 048 (olaparib expanded) expansion cohorts: Phase 2 study of olaparib monotherapy in patients (pts) with metastatic breast cancer (MBC) with germline (g) mutations in PALB2 or somatic (s) mutations in BRCA1 or BRCA2
    Meeting Abstract

    Tung, N. M.; Robson, M. E.; Nanda, R.; Li, T.; Vinayak, S.; Shah, P. D.; Khoury, K.; Kimmick, G. G.; Santa-Maria, C. A.; Brufsky, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Enfortumab vedotin (EV) in triple-negative breast cancer (TNBC) and HR+/HER2-breast cancer (BC) cohorts of EV-202
    Meeting Abstract

    Giordano, A.; Awan, A. A. A.; Bruce, J. Y.; Rugo, H. S.; Diamond, J. R.; Novik, Y.; Baranda, J. C.; Muro, K.; Ono, M.; Nanda, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save